NASDAQ:SWTX strong revenue seeing positive reaction. Bouncing off yesterday's high.
SPRINGWORKS THERAPEUTICS INC. SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford,...
Double dip, butterflies and new support suggest this could move towards $50. This is also supported by bullish broker sentiment.
Massive breakout potential setting up. Short interest 7% Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is...